BioSpace News Archive

Greenwich LifeSciences, Inc. today provides an update on the upcoming Phase III clinical trial FLAMINGO-01.

Click Therapeutics, Inc. today announced that David Benshoof Klein, Co-Founder and CEO, and Randall Stanicky, Chief Financial Officer, will take part in the virtual BTIG Digital Health Forum on Monday, November 15, 2021.

Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s (USAMRDC) Military Infectious Diseases Research Program (MIDRP) to accelerate clinical development of an antibiofilm version of its next-generation Microlyte® Matrix wound dressing that can kill bacteria hidden in biofilms.

Arbutus Biopharma Corporation today announced that the Company will participate in a virtual fireside chat at the Jefferies London Healthcare Conference.

Monte Rosa Therapeutics, Inc. today reported business highlights and financial results for the third quarter, ended Sept. 30, 2021.

Kaleido Biosciences, Inc. today announced the appointment of Alison Long, M.B.B.Ch., Ph.D., to its leadership team as Chief Medical Officer, effective December 15, 2021.

Decibel Therapeutics today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update.

Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates. Research and development update to be held on Thursday, December 16, 8:00-9:30 AM EST

Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update